promegestone and u 0126
promegestone has been researched along with u 0126 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Faivre, E; Horwitz, KB; Lange, CA; Olsen, A; Qiu, M | 1 |
| Edwards, DP; Holley, AK; Jenkins, JT; Kiningham, KK; Moore, MR; Spitz, DR | 1 |
| Karteris, E; Mparmpakas, D; Rand-Weaver, M; Thomas, P; Zachariades, E | 1 |
Other Studies
3 other study(ies) available for promegestone and u 0126
| Article | Year |
|---|---|
Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors.
Topics: Acetylcysteine; Active Transport, Cell Nucleus; Breast Neoplasms; Butadienes; Cell Nucleus; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Cytoplasm; Epidermal Growth Factor; Fatty Acids, Unsaturated; Humans; Ligands; Mitogen-Activated Protein Kinase Kinases; Multienzyme Complexes; Mutation; Nitriles; Phosphorylation; Promegestone; Proteasome Endopeptidase Complex; Receptors, Progesterone; Serine; Transcription, Genetic; Tumor Cells, Cultured | 2003 |
Progestin stimulation of manganese superoxide dismutase and invasive properties in T47D human breast cancer cells.
Topics: Base Sequence; Breast Neoplasms; Butadienes; Cell Line, Tumor; DNA Primers; Female; Hormone Antagonists; Humans; MAP Kinase Signaling System; Mifepristone; Neoplasm Invasiveness; Nitriles; Progesterone Congeners; Promegestone; Receptors, Progesterone; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Superoxide Dismutase | 2009 |
Crucial cross-talk of interleukin-1β and progesterone in human choriocarcinoma.
Topics: Butadienes; Cell Death; Cell Line, Tumor; Choriocarcinoma; Female; Humans; Interleukin-1beta; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Phosphorylation; Pregnancy; Progesterone; Promegestone; Protein Kinase Inhibitors; Receptors, Progesterone; Signal Transduction; Time Factors; Tumor Microenvironment; Uterine Neoplasms | 2012 |